| Date Initiated by Firm | September 11, 2026 |
| Date Posted | November 17, 2026 |
| Recall Status1 |
Open3, Classified |
| Recall Number | Z-0467-2027 |
| Recall Event ID |
99973 |
| Product Classification |
laparoscopy kit - Product Code FDE
|
| Product | Generic Name: Halyard
Generic Name: Laparoscopy Comprehensive Pack II
Model/Catalog Number: 49332
Software Version: N/A
Product Description: Laparoscopy Comprehensive Pack II
Component: Not a component |
| Code Information |
Lot Code: Model No.#49332;
UDI-DI: 10680651493320 (units); 30680651493324 (case)
Lot #1: GL25271CXA ; Exp Date: 2029/03/30
Lot #2: GL25296CXA ; Exp Date: 2029/03/30
Lot #3: GL26076CXA ; Exp Date: 2029/05/31
|
| FEI Number |
3014421917
|
Recalling Firm/ Manufacturer |
O&M HALYARD INC
1220 Old Alpharetta Rd Ste 320
Alpharetta
GA
30005-3946
|
| For Additional Information Contact | Jim Marshall +1-844-4259273 |
Manufacturer Reason for Recall | Inconsistent latex free labeling. The laparoscopy comprehensive pack contains a component that contains "Nature Rubber Latex", but product labeling indicates "Not made with natural rubber latex". |
FDA Determined Cause 2 | Under Investigation by firm |
| Action | On 09/11/2026, a "FIELD ACTION: CUSTOMER NOTIFICATION" letter was emailed to customers informing them that, The Laparoscopy Comprehensive Pack II #49332-00 has a component Latex Urethral Catheter , this component was confirmed contains Nature Rubber Latex , which is inconsistent with the Not made with natural rubber latex on product case and sterile insert label. These defect compromise to the patient or clinician with sensitivity to natural rubber latex which leads to the field action.
Customer are instructed to:
Review inventory, and segregate and quarantine all affected product code and lot(s). All other product code and lot of this product are NOT impacted by this Field Action.
Distributors/Customer (end-users):
1. REVIEW inventory for the affected product code(s) and specific lot number(s).
2. RETURN all the affected products available in inventory.
3. COMMUNICATE voluntary Field Action to staff to ensure awareness.
4. If any of the affected product code(s) and lot(s) identified were further distributed, ensure all end-users are appropriately notified of this Field Action and maintain records of effectiveness.
5. Any adverse events associated with the use of the affected product(s) should be reported to complaints@owens-minor.com.
6. RETURN the completed Field Action Response Form to GM-OMRA_RECALLS@owens-minor.com as soon as possible even if you have no current product inventory.
For any questions, email GM-OMRA_RECALLS@owens-minor.com using the Event # FA-2026-058 in the header of the response. |
| Quantity in Commerce | 396 |
| Distribution | U.S. Nationwide distribution in the states of CA and MI. |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes.
|